Recombinant Human TPK1 Protein，His

TPK1, or Thymidine Phosphorylase Kinase 1, is a vital enzyme involved in nucleotide metabolism, playing a crucial role in the salvage pathway of thymidine and influencing cellular responses to various stressors, including oxidative stress. The interest in TPK1 recombinant protein has surged in recent years due to its potential implications in cancer biology and therapeutic applications. Elevated levels of TPK1 have been associated with increased tumorigenicity and resistance to chemotherapeutic agents, making it a significant target for drug development and biomarker identification. Furthermore, TPK1's involvement in the regulation of angiogenesis highlights its importance in tumor progression and metastasis. The production of recombinant TPK1 allows for in-depth studies into its structure-function relationships, enabling researchers to explore its enzymatic mechanisms and interactions with substrates, inhibitors, and other cellular components. By utilizing recombinant technology, scientists can generate large quantities of pure TPK1 for biochemical assays, structural analyses, and potential therapeutic interventions. Understanding the intricacies of TPK1's role could not only advance our knowledge of tumor biology but also pave the way for innovative strategies in cancer treatment and management. Therefore, the study of TPK1 recombinant protein is pivotal in both basic research and the development of future therapeutic approaches targeting malignancies linked to dysregulated nucleotide metabolism and cellular stress responses.